Previous Article | Next Article 
Molecular and Cellular Biology, September 1999, p. 6048-6056, Vol. 19, No. 9
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
E2F4 Actively Promotes the Initiation and
Maintenance of Nerve Growth Factor-Induced Cell Differentiation
Stephan P.
Persengiev,
Ivanela I.
Kondova,
and
Daniel L.
Kilpatrick*
Department of Cellular and Molecular
Physiology, University of Massachusetts Medical School, Worcester,
Massachusetts 01655
Received 16 December 1998/Returned for modification 10 February
1999/Accepted 22 February 1999
 |
ABSTRACT |
E2F transcription factors play a critical role in cell cycle
progression through the regulation of genes required for
G1/S transition. They are also thought to be important for
growth arrest; however, their potential role in the cell
differentiation process has not been previously examined. Here, we
demonstrate that E2F4 is highly upregulated following the neuronal
differentiation of PC12 cells with nerve growth factor (NGF), while
E2F1, E2F3, and E2F5 are downregulated. Immunoprecipitation and
subcellular fractionation studies demonstrated that both the nuclear
localization of E2F4 and its association with the Rb family member p130
increased following neuronal differentiation. The forced expression of
E2F4 markedly enhanced the rate of PC12 cell differentiation induced by
NGF and also greatly lowered the rate at which cells lost their
neuronal phenotype following NGF removal. Importantly, this effect
occurred in the absence of any significant change in the growth
regulation of PC12 cells by NGF. Further, the downregulation of E2F4
expression with antisense oligodeoxynucleotides inhibited NGF-induced
neurite outgrowth, indicating an important role for this factor during PC12 cell differentiation. Finally, E2F4 expression was found to
increase dramatically in the developing rat cerebral cortex and
cerebellum, as neuroblasts became postmitotic and initiated terminal
differentiation. These findings demonstrate that, in addition to its
effects on cell proliferation, E2F4 actively promotes the neuronal
differentiation of PC12 cells as well as the retention of this state.
Further, this effect is independent of alterations in cell growth and
may involve interactions between E2F4 and the neuronal differentiation
program itself. E2F4 may be an important participant in the terminal
differentiation of neuroblasts.
 |
INTRODUCTION |
While cell differentiation and
growth arrest are distinct processes that can occur independently, they
are generally intimately linked, with cell cycle exit being a
prerequisite for terminal differentiation. For example, proliferating
neuroblasts already exhibit several neuronal features, but the onset of
terminal differentiation does not occur until the final cell division
(14, 45). Clearly, mechanisms operating at the interface
between the growth arrest and differentiation programs play critical
roles in establishing the differentiated states of neurons and other
cell types. Such mechanisms are also likely to be important in
maintaining the irreversibility of terminal differentiation, and their
disruption plays an important role in cell immortalization and
tumorigenesis. Several cell cycle-associated proteins have been
directly implicated in the terminal differentiation process, including
the retinoblastoma protein (pRb) and the cyclin-dependent kinase
inhibitor p21/WAF1 (17, 19). Importantly, recent studies
have shown that these proteins have dual regulatory effects on cell
cycle progression and cell differentiation that occur by distinct
mechanisms (12, 47).
Members of the E2F family of transcriptional regulators have a central
role in the cell cycle-dependent expression of genes required for DNA
synthesis and S-phase entry, and functional studies have provided
direct evidence for their involvement in the G1/S transition as well as apoptosis (for a review, see references 22 and 40). Six E2F family
members have been characterized (E2F1 through E2F6), and they exhibit
various degrees of structural relatedness (6, 13, 22, 51).
E2Fs exist as heteromeric complexes consisting of an E2F and a DP
family member (the so-called "free" E2F) and, with the exception of
E2F6, also associate with a retinoblastoma (Rb) family member under
specific conditions. Dimerization with a DP family member is necessary
for optimal E2F transcriptional activity, while complex formation with
Rb family members converts E2Fs into repressors of E2F-regulated genes.
The ectopic expression of E2F1, E2F2, or E2F3 is sufficient to induce
S-phase entry, while E2F4 or E2F5 by itself cannot (33). This difference apparently reflects the fact that nuclear import of
E2F4 or E2F5 is cell cycle dependent (32, 35, 54).
While E2Fs are clearly important for cell cycle progression, little is
currently known about their potential functions during cell
differentiation. Differential changes in the expression or activities
of E2Fs following cell cycle exit and differentiation have been
demonstrated for several cell types, with E2F4 often being the
predominant species (42, 48, 53, 56). In certain differentiated tissues, E2F5 appears to be selectively induced (11). These observations suggest that, in addition to
contributing to cell proliferation, E2F4 and E2F5 may be important
transcriptional regulators of growth arrest and/or differentiation.
However, the direct demonstration of the ability of these
transcriptional regulators to promote cell differentiation has been
lacking. In the present study, we show that E2F4 enhances both the
initiation and maintenance of nerve growth factor (NGF)-induced
differentiation of PC12 cells into sympathetic-like neurons and that
these effects do not involve changes in the regulation of cell growth.
We also demonstrate that inhibition of E2F4 protein levels interferes
with the differentiation process.
 |
MATERIALS AND METHODS |
Cell cultures.
PC12 cells were grown on collagen-coated
plates in Dulbecco's modified Eagle medium (DMEM) with or without 10%
horse serum-5% fetal bovine serum and incubated at 37°C in 10%
CO2. To induce neuronal differentiation, cells were treated
with 50 ng of NGF (Harlan Bioproducts) per ml for various times. In
washing experiments, NGF-treated cells were rinsed three times with
DMEM with or without serum and cultured for up to four additional days.
Plasmids and stable transfections.
The plasmid pUHD15-1neo,
containing the tetracycline resistance repressor (tTA) fused in frame
with the activation domain of virion protein 16 of the herpes simplex
virus, and the expression vector pTETHAE2F4, containing the human E2F4
sequence inserted into pUHD10-3, have been described (33).
PC12 cells were transfected with equimolar amounts of pTETHAE2F4 and
pUHD15-1neo with Lipofectamine (GIBCO/BRL). Cells were allowed to
recover for 72 h prior to selection with G418 (200 µg/ml) and
tetracycline (2 mg/ml). Multiple colonies of PC12 cell derivatives
(E2F4-tet cells) were isolated, and the E2F4 induction and
differentiation responses of two of these colonies were fully
characterized. The colonies behaved very similarly to each other and to
the original population of pooled clones.
RNA isolation and analysis.
Total RNA was isolated from PC12
cells and rat cerebral cortex by the guanidinium isothiocyanate-CsCl
method, and Northern blot analyses were performed as previously
described (27). The various probes used for Northern
analysis were generated by restriction digestion with the following:
(i) for E2F1, a StyI-XhoI fragment from
pSp72-RBAP1 (26); (ii) for E2F3, a
BamHI-BamHI fragment from pCMV-E2F3
(38); (iii) for E2F5, an XbaI-HincII
fragment from pCMV-E2F5 (23); and (iv) for cyclin A, an
EcoRI-SphI fragment from pCycA (55).
The amount of RNA in each lane was normalized with a human GAPDH
(glyceraldehyde-3-phosphate dehydrogenase) cDNA probe generated by
PstI digestion of pHcGAP (52).
Protein extracts and Western blotting.
Whole-cell extracts
from PC12 cells and rat cortex and cerebellum were prepared as
previously described (2). Briefly, cells were homogenized in
whole-cell extraction buffer containing 20 mM HEPES (pH 7.9), 400 mM
NaCl, 1 mM EDTA, 10 mM dithiothreitol, 1 mM phenylmethylsulfonyl
fluoride, 25% glycerol, 2 mg of pepstatin A per ml, 5 mg of leupeptin
per ml, 5 mg of ubenimex (Bestatin) per ml, and 5 mg of aprotinin per
ml and centrifuged for 10 min at 15,000 × g.
Supernatants were used for analysis. Extracts were separated on sodium
dodecyl sulfate (SDS)-10% polyacrylamide gels, blotted onto
polyvinylidene difluoride membranes, and reacted with rabbit antibodies
against E2F1, E2F4, E2F5, pRb, p107, p130, cyclin A, Sp1 (Santa Cruz
Biotech), and
-tubulin type III (Sigma). Incubations were carried
out in Tris-buffered saline containing 0.1% Tween 20 and 10% nonfat
dry milk for 1 h at room temperature. Protein bands were
visualized by enhanced chemiluminescence (kit from DuPont/NEN, Boston,
Mass.).
Cellular analyses.
The extent of neurite outgrowth in
E2F4-tet PC12 cell derivatives was determined by the ratio of neurite
length to cell body diameter (9) (at least 300 to 400 cells
were counted for each data point). The number of viable cells was
determined by cell counting by trypan blue exclusion. The rate of DNA
synthesis in E2F4-tet cells was determined by labelling 0.5 × 106 cells for 2 h with 1 µCi of
[3H]thymidine. Washed cells were extracted at various
times with 2 N NaOH. Significance was examined by a one-way analysis of
variance, followed by Bonferroni multiple-comparison testing.
Isolation of nuclear and cytoplasmic fractions.
For nuclear
and cytoplasmic extracts, cells were homogenized in 10 mM HEPES (pH
7.2) containing 150 mM NaCl, 1.5 mM MgCl2, and protease
inhibitors. Complete cellular disruption was verified by trypan blue
exclusion, and nuclear and cytoplasmic fractions were generated by
centrifugation at 800 × g for 10 min. The nuclear pellet was washed once with hypotonic buffer and then lysed with radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris-HCl [pH 8.1], 150 mM NaCl, 0.2% SDS, 1% sodium deoxycholate, 1% Nonidet P-40, 5 mM EDTA).
Immunoprecipitations.
Immunoprecipitations were performed on
200 µg of whole-cell extracts in a final volume of 0.2 ml at 4°C
for 1 h with 10 µg of p130 antibody (sc-317; Santa Cruz
Biotech). Protein A/G Plus agarose (Santa Cruz Biotech) was then added,
and incubations were continued for an additional 16 h at 4°C.
Pellets were collected by centrifugation, washed four times with
whole-cell extraction buffer, and dissolved in electrophoresis sample
buffer. Immunoprecipitates were resolved on SDS-10% polyacrylamide
gels, transferred to polyvinylidene difluoride membranes, and probed
with E2F4 antiserum (sc-866; Santa Cruz Biotech).
Antisense ODN treatment.
Synthetic phosphorothioate
oligodeoxynucleotides (ODNs) were obtained from Oligos Etc. (Redding
Center, Conn.). E2F4 antisense ODNs were based on conserved mouse and
human E2F4 sequences (3, 46) and were as follows: AS1,
5'-GCCTCCGCCATCGC-3' (residues +14 to
3 in mouse E2F4
cDNA); AS2, 5'-CCTGTGGCCCGGCCTCCG-3' (residues +22 to +5);
and AS3, 5'-TCGTGCCGGCTTGGAGTC-3' (residues +56 to +89).
Control ODNs contained either the sense sequences complementary to AS1
and AS3 (S1 and S3) or the unrelated sequences
5'-AGCCTCCGCCAGCAAGGCTGC-3' (CS1) and
5'-GTTTTGAGCAGCCATGGTGGA-3' (CS2). Treatment of PC12 cells
with ODNs (5 µM) was performed with or without NGF in the presence of
Transfast reagent (Promega, Madison, Wis.) as recommended by the
manufacturer. Fresh ODNs were added every 48 h for up to 6 days
during NGF treatment.
 |
RESULTS |
Regulation of E2F and Rb family members during neuronal
differentiation of PC12 cells.
We utilized the PC12 cell model to
explore the role of E2Fs during neuronal differentiation. These
pheochromocytoma cells undergo growth arrest and differentiation into
postmitotic sympathetic-like neurons in the presence of NGF and
faithfully reproduce many important features of sympathetic
differentiation, including neurite outgrowth, regulation of cell
cycle-associated genes, and NGF-dependent survival (7, 37, 49,
59). Exposure of PC12 cells to 50 ng of NGF per ml for 8 days in
the absence of serum or for 14 days in the presence of serum markedly
downregulated the levels of protein and/or mRNA for E2F1, E2F3, and
E2F5 (Fig. 1). In contrast, E2F4 protein
levels were markedly increased in differentiated PC12 neurons (Fig.
1B). The increase in E2F4 protein levels was even greater in neuronal
derivatives generated in the absence of serum, due to the upregulation
of E2F4 by serum removal alone (Fig. 1B), while the expression of E2F5
protein and mRNA was inhibited under serum-free conditions (Fig. 1).
Thus, E2F4 protein levels increase markedly following PC12 cell
differentiation, while the levels of other E2F proteins are greatly
diminished or extremely low.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 1.
Expression of E2F and Rb family members following NGF
treatment of PC12 cells. (A) Northern analysis. GAPDH mRNA was used to
monitor the relative loading of total RNA (30 µg/lane). (B) Western
analysis (30 µg of protein/lane). Cells were cultured in the presence
or absence of serum and with or without NGF for 6, 8, or 14 days, as
indicated. Cells were treated with NGF for a longer time in the
presence of serum, since the differentiation response is slower under
these conditions (15).
|
|
Analysis of Rb family members revealed that pRb and p107 proteins also
were suppressed in neuronal derivatives, while p130
was unchanged (Fig.
1B). We also examined the regulation of cyclin
A and cdk2, both of
which are important for cell cycle regulation
and one of which (cyclin
A) is regulated by E2Fs in PC12 cells
(
22). In both cases,
expression was markedly suppressed following
NGF-induced
differentiation (Fig.
1).
E2F4 binds p130 and localizes to the nucleus following PC12 cell
differentiation.
E2F4 interactions with Rb family proteins have a
major impact on E2F4 function, including its conversion from a
trans-activator into a repressor of E2F-regulated cell cycle
genes (22, 39). In differentiated and growth-arrested cells,
E2F4 is often associated with the Rb family member p130 (8, 42,
53, 57), and the fact that p130 was unchanged by the NGF-induced
differentiation of PC12 cells, while pRb and p107 were downregulated,
suggests that E2F4-p130 complexes may exist in these neuronal
derivatives. p130-containing complexes were immunoprecipitated and
examined for the presence of E2F4. E2F4 protein was not detectable in
p130 immunoprecipitates derived from proliferating PC12 cells but was clearly evident in complexes from cells treated with NGF (Fig. 2A). The number of E2F4-p130 complexes
was higher in PC12 cells treated with NGF in the absence of serum than
in cells treated in the presence of serum, which was consistent with
the increased concentrations of total E2F4 protein in these cells.
Also, E2F4 was readily detected in p130 immunoprecipitates derived from
PC12 cells cultured in serum-free medium alone. The negative control protein Sp1 was undetectable on immunoblots of the same p130
precipitates (data not shown). Thus, E2F4 associates with p130 in PC12
cells following growth arrest and neuronal differentiation.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 2.
E2F4 associates with p130 and localizes to the nucleus
in neuronal derivatives of PC12 cells. Wild-type cells were cultured
with or without serum and with or without NGF for 8 days. (A) p130
complexes were immunoprecipitated (IP) with p130 antibodies from 200 µg of whole-cell extracts and subjected to Western blot (immunoblot
[IB]) analysis with E2F4 antiserum. (B) Western blot analysis of
nuclear (n) and cytosolic (c) protein fractions from wild-type PC12
cells. A total of 50 µg of protein was loaded per lane. Transcription
factor Sp1 was used as a nuclear marker.
|
|
An additional effect of the interaction of E2F4 with Rb family proteins
is increased nuclear localization and, therefore,
enhanced
transcriptional regulation (
32,
35,
54). This was
examined
by the subcellular fractionation of PC12 cells with the
transcription
factor Sp1 as a marker for the nuclear fraction
(
25).
Expression of Sp1 in PC12 cells is unaffected by NGF treatment
(
58). The ratio of E2F4 within the nuclear and cytosolic
fractions
increased considerably following NGF treatment for 8 days
(Fig.
2B). This was particularly evident in cells which differentiated
in serum-free medium (the presence of significant amounts of cytosolic
E2F4 in cells which differentiated in the presence of serum likely
reflects the fact that differentiation proceeds more slowly under
these
conditions [
15] and is incomplete after 8 days of NGF
treatment). The majority of E2F4 in growth-arrested, serum-deprived
PC12 cells was also associated with the nuclear fraction (Fig.
2B).
These findings indicate that E2F4 is mainly or exclusively
localized in
the nucleus following neuronal
differentiation.
Development of PC12 cell derivatives expressing E2F4 under the
control of a tetracycline-regulated promoter.
The above results
suggested that E2F4 has a primary role in neuronal differentiation
relative to other E2Fs. To directly investigate this, we developed PC12
cell derivatives stably transfected with a tetracycline-regulated
expression plasmid for this factor, together with a constitutively
active vector encoding the tetracycline transactivator tTA. With this
system, E2F4 expression is repressed in the presence of tetracycline
and induced following its removal. Multiple cell lines (E2F4-tet cells)
were generated and examined for the expression of E2F4 in the presence
and absence of tetracycline (Fig. 3A). No
E2F4 protein was detected in noninduced, proliferating E2F4-tet cells,
indicating tight regulation of the expression vector by tetracycline.
In contrast, E2F4 was readily detected following tetracycline removal.
The levels of induced E2F4 protein were, in fact, similar to those
obtained following growth arrest and differentiation of uninduced PC12
cells (Fig. 3A) and thus were quite physiological. Under serum-free,
growth-arrested conditions in which endogenous E2F4 is upregulated, the
removal of tetracycline resulted in a further, apparently additive
increase in E2F4 levels. Similarly, tetracycline removal resulted in a
marked increase in E2F4 levels in cells treated with NGF for 6 days in
either the presence or absence of serum (Fig. 3A). Thus, E2F4-tet cells exhibit substantial induction of E2F4 expression in proliferating, quiescent, and differentiated PC12 cells.




View larger version (168K):
[in this window]
[in a new window]
|
FIG. 3.
E2F4 induction accelerates the differentiation response
of PC12 cells. (A) Western analysis of E2F4 protein expression in
E2F4-tet cells. Cells were cultured for 6 days in the presence or
absence of NGF and tetracycline (tet) in serum-free or serum-containing
medium. Ectopic E2F4 expression was induced following the removal of
tetracycline. (B) Effect of E2F4 induction on the morphological
differentiation of PC12 cells by NGF. Phase-contrast microscopy of
E2F4-tet PC12 cells cultured with or without NGF for 4 days in the
presence of serum was done. Tetracycline was either present in (E2F4
off) or absent from (E2F4 on) the culture medium. (C) Quantitation of
neurite outgrowth in E2F4-tet cells following NGF treatment. The extent
of outgrowth was determined by the ratio of neurite length to cell body
diameter (9). Results are presented as the percentage of
total cells counted and represent means + standard errors of three
to four independent experiments. The x axis shows cell body
diameters. Cells were cultured in either the presence (black bars, not
induced) or absence (shaded bars, induced) of tetracycline and were
treated with NGF in serum-containing DMEM for 2 to 8 days. One-way
analysis of variance was used for statistical analysis. *,
P < 0.05; **, P < 0.01; ***, P < 0.001. (D) Western analysis of -tubulin expression in E2F4-tet
cells. Cell extracts were analyzed at various days following NGF
treatment in the presence of serum, with and without tetracycline (tet)
in the culture medium. The same membrane was reprobed with antibodies
against transcription factor Sp1.
|
|
Effects of E2F4 induction on neuronal differentiation of PC12
cells.
To examine its effects on PC12 cell differentiation, E2F4
was induced prior to the initiation of NGF treatment. Control studies verified that tetracycline treatment had no effect on either the differentiation of wild-type PC12 cells or their response to NGF withdrawal (data not shown). E2F4-tet cells were treated with 50 ng of
NGF per ml for up to 8 days in serum-containing medium in the presence
and absence of tetracycline. Major differences in the rate of
morphological differentiation that were most dramatic after 2 to 3 days
of NGF treatment were observed (Fig. 3B). E2F4-induced cells had a much
more mature neuronal appearance at this time, including a flattened
morphology and the prevalence of markedly longer neurites. In contrast,
E2F4 induction did not alter the morphology of proliferating PC12 cells
(data not shown).
The effects of E2F4 preinduction on PC12 cell differentiation were
quantified by determining the ratio of neurite length to
cell body
diameter. Cells were classified according to this ratio
(<1, 1 to 2, and >2 cell body diameters), with more-differentiated
cells possessing
higher values. On day 2 of NGF treatment, >70%
of E2F4-induced cells
were significantly differentiated (bearing
neurites 1 cell diameter or
greater in length), while only 25%
of uninduced cells possessed
neurite lengths of 1 to 2 cell diameters;
none had neurites longer than
2 cell diameters (Fig.
3C). By day
8 of NGF treatment, 100% of
uninduced cells exhibited a differentiated
phenotype, and thus E2F4
enhancement of differentiation could
no longer be
detected.
The neuronal marker

-tubulin type III (
18) was used to
monitor the effects of E2F4 preinduction on the biochemical
differentiation
of PC12 cells by NGF.

-Tubulin protein levels
increased following
the NGF treatment of E2F4-tet cells, and the rate
of this increase
was substantially higher when E2F4 was preinduced
(Fig.
3D) on
days 2 and 4 of NGF treatment. Thus, the ectopic
expression of
E2F4 markedly enhances the onset of neuronal
differentiation in
PC12
cells.
E2F4 and maintenance of the neuronal phenotype.
A
characteristic feature of NGF-treated PC12 cells is their ability to
undergo reversible differentiation and renewed proliferation upon NGF
removal in the presence of serum (16). Western analysis demonstrated that E2F4 protein decreased to undetectable levels after
the removal of NGF from differentiated PC12 cells and further culturing
for 4 days in the presence of serum, while the expression of both E2F1
and E2F5 increased (Fig. 4A). We
therefore examined whether ectopic expression of E2F4 would promote
retention of the differentiated state in neuronal derivatives
undergoing dedifferentiation. E2F4-tet cells were differentiated with
NGF in the presence of serum for 8 days with and without tetracycline
and then washed and cultured in serum-containing medium alone. Cells in
which E2F4 was induced (without tetracycline) lost neurites at a
considerably lower rate than uninduced E2F4-tet cells after NGF removal
(Fig. 4B). The number of cells possessing neurites of 1 to 2 cell body diameters or more was 4.3-fold higher on the fourth day of washing (Fig. 4C). Further, the expression of
-tubulin type III decreased at
a lower rate following NGF removal from induced E2F4-tet cells (Fig.
4D).




View larger version (199K):
[in this window]
[in a new window]
|
FIG. 4.
Effect of E2F4 induction on the response of
differentiated PC12 cells to NGF withdrawal. (A) Western analysis of
E2F protein expression following removal of NGF from wild-type PC12
cells. PC12 cells were treated with NGF in serum-containing medium for
14 days and then washed (w) and cultured with serum for up to 4 days.
(B) Phase-contrast microscopy of E2F4-tet cells treated with NGF in the
presence of serum for 8 days, then washed three times to remove NGF,
and incubated in either the presence [wash (+)] or absence [wash
( )] of serum for 2 days, as indicated. Tetracycline was either
present in (E2F4 off) or absent from (E2F4 on) the culture medium. (C)
Neurite outgrowth in E2F4-tet derivatives following the washing of
NGF-treated cells. Cells were treated with NGF in serum-containing DMEM
for 8 days and then were washed in medium with or without serum for 2 or 4 days. Data were analyzed as for Fig. 3. (D) Western analysis of
-tubulin expression. E2F4-tet cells were treated with NGF in
serum-containing medium for 8 days with or without tetracycline (tet)
and then either harvested (8 days) or washed (w) and cultured in the
absence of NGF for 2 or 4 days. The same membrane was probed for Sp1
protein as an internal control.
|
|
Neuronal derivatives of PC12 cells lose their neurites and subsequently
die via an apoptotic mechanism if cultured in serum-free
medium without
NGF (
37). When differentiated E2F4-tet cells
were washed and
cultured in medium lacking both serum and NGF,
the induced cells
retained their differentiated morphology to
a much greater degree than
did the uninduced cells (Fig.
4B).
This effect was particularly
dramatic on the fourth day following
NGF removal, when >90% of
induced E2F4-tet cells contained neurites
of intermediate length or
greater while no uninduced cells had
this phenotype (Fig.
4C). Thus, in
addition to accelerating the
onset of neuronal differentiation, E2F4
also promotes the maintenance
of the differentiated state of PC12
cell-derived
neurons.
Growth regulation in E2F4-induced PC12 cells during
differentiation.
In contrast to its impact on cell
differentiation, E2F4 induction had no significant effect on DNA
synthesis or cell number in PC12 cells undergoing growth arrest and
differentiation in response to NGF (Fig.
5A and data not shown). Similarly, these parameters were unaltered during the dedifferentiation and growth renewal of PC12 cell-derived neurons following NGF withdrawal in the
presence of serum (Fig. 5B and data not shown). The ectopic expression
of E2F4 also had no major effect on the survival rate of NGF-deprived
neuronal derivatives in serum-free medium, although there was a trend
toward decreased cell loss (data not shown). Thus, E2F4 enhancement of
both the onset and retention of PC12 cell differentiation is
independent of any marked alteration of growth arrest or cell
proliferation.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 5.
Induction of E2F4 does not alter DNA synthesis in
NGF-treated PC12 cells. (A) [3H]thymidine incorporation
was determined during the differentiation response to NGF. Cells were
treated with NGF in serum-containing medium for 2, 4, or 8 days in
either the presence (black bars, uninduced) or absence (shaded bars,
induced) of tetracycline. (B) DNA synthesis was determined following
washing of differentiated E2F4-tet cells. Cells were treated with NGF
in the presence of serum for 8 days and then washed and cultured with
(+) or without ( ) serum in either the presence or absence of
tetracycline, as for panel A. Data are expressed as the means ± standard errors of three to four independent experiments.
|
|
Role of endogenous E2F4 in neuronal differentiation of PC12
cells.
To determine whether E2F4 was normally involved in PC12
cell differentiation, antisense ODNs (AS1 to AS3) were designed for sequences spanning or adjacent to the translation initiation region which are unrelated to sequences within the other E2Fs. All three antisense ODNs markedly reduced the expression of E2F4 in NGF-treated PC12 cells, with AS1 and AS2 being more effective than AS3 (Fig. 6A). When tested for their effects on
NGF-dependent neurite outgrowth from PC12 cells, the antisense ODNs
inhibited this process with the same order of efficacy, while sense or
unrelated control ODNs had negligible effects on both E2F4 protein
levels and neurite outgrowth (Fig. 6 and data not shown). Thus, E2F4
has an important regulatory role in the NGF-induced differentiation of
PC12 cells.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 6.
Analyses with antisense ODNs. (A) Analysis of E2F4 and
Sp1 proteins in extracts following ODN treatment of PC12 cells. PC12
cells were treated with NGF for 6 days in the presence or absence of
ODNs. (B) Neurite outgrowth in PC12 cells following antisense-ODN
treatment for 5 days. The percentage of total cells bearing neurites
more than 2 cell body diameters in length were determined. Results are
expressed relative to those for cells treated with NGF in the absence
of ODNs and are the averages of five independent experiments. N, cells
treated with NGF without ODN; C1, control unrelated ODN.
|
|
Regulation of E2F4 expression during development of the rat central
nervous system.
We also examined whether the pattern of E2F
expression in developing neural tissue was similar to that observed in
differentiating PC12 cells. During neurogenesis of the rat cerebral
cortex, proliferating neuroblasts within the subventricular zone become
postmitotic and begin their migration to upper cortical layers in a
wave occurring in the late embryonic and early postnatal period
(36). An analysis of the rat cerebral cortex revealed that
the expression of both E2F1 and E2F5 was downregulated as cortical
neurons became postmitotic between E18 and P1 to P3 (Fig. 7A and
B). Cyclin A expression was similarly
downregulated in the cerebral cortex, as previously reported
(21). In contrast, E2F4 protein was substantially
upregulated during this period of terminal growth arrest and neuronal
differentiation (Fig. 7B).

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 7.
Developmental regulation of E2F gene expression in rat
central nervous system. Rat cortex (A and B) and cerebellum (C) were
examined. (A) Northern analysis was performed as for Fig. 1. (B and C)
Western analyses. Thirty micrograms each of total RNA and protein
extracts was loaded per lane.
|
|
Similar analyses were performed with developing rat cerebellum. During
postnatal weeks 2 and 3, granule cell neuroblasts within
the
extragranular layer terminally exit the cell cycle and migrate
inward
(
1). Western analysis of rat cerebellar extracts during
this
period revealed a gradual but large increase in E2F4 expression
(Fig.
7C). In contrast, E2F5 protein was essentially undetectable
during this developmental period in the rat cerebellum (data not
shown). Thus, E2F4 is upregulated in the rat central nervous system
as
neuroblasts become postmitotic and differentiate, as occurs
in PC12
cell-derived
neurons.
 |
DISCUSSION |
E2FA facilitates the differentiation process.
E2F4 is one of a
family of factors known to be critical for normal progression through
the G1 and S phases of the cell cycle. The present studies
have demonstrated an additional activity for this factor, specifically
in the differentiated state. The expression of E2F4 increases markedly
in neuronal derivatives of PC12 cells, and its ectopic expression
enhances both the initiation of neuronal differentiation and its
maintenance when examined under reversal conditions. Further,
experiments with antisense ODNs have shown that E2F4 is an important
regulator of NGF-induced differentiation. To our knowledge, this is the
first demonstration of a direct role for mammalian E2F factors in
promoting the differentiation of any cell lineage. Mutation studies of
the Drosophila melanogaster E2F gene have previously
suggested a role for this factor in postmitotic cells (5),
and a nonproliferative function in secretion by epithelial cells of the
choroid plexus was recently demonstrated for mouse E2F5 in gene
knockout studies (31). The present findings suggest that
E2F4 may have therapeutic potential in inhibiting the reversal of
differentiation that often follows the treatment of certain tumors with
differentiating agents (20).
While important for the neuronal differentiation of PC12 cells, E2F4
induction by itself was not sufficient to initiate this
process. This
is not surprising in light of the dual roles of
E2F4 in cell cycle
progression and differentiation. To promote
differentiation, E2F4
presumably must form complexes with factors
which promote its nuclear
localization and appropriately regulate
its transcriptional activity.
That is, its nuclear entry depends
on its association with either a DP
or Rb partner (
32,
35,
54), and the nature of the
facilitating partner(s) is an important
determinant of its
transcriptional activity: e.g., DP partners
enhance transactivation,
while Rb proteins convert the E2F complex
into a transrepressor.
Association with p130 is, therefore, presumably
important for the
nuclear localization and function of E2F4 during
the neuronal
differentiation of PC12 cells. In contrast to the
present results, the
ectopic expression of E2F4 induces cell cycle
reentry in quiescent
muscle cells when overexpressed with DP3
(
43). This
apparently reflects limiting levels of Rb family
members under the
latter conditions, since E2F4 complexes formed
with p130 and p107 are
associated with growth arrest in these
cells. Thus, whether E2F4
promotes cell proliferation or differentiation
is determined to a great
degree by the nature of its associated
partners.
E2Fs and terminal differentiation of neuroblasts.
The terminal
differentiation of postmitotic neurons is not initiated until permanent
exit from the cell cycle (36), and this event represents a
critical juncture in nervous system development. Loss of either pRb or
p130 leads to the uncontrolled proliferation and subsequent apoptosis
of central and peripheral neuroblasts, as well as the incomplete
differentiation of surviving cells (28, 29). Studies
employing adenovirus E1A proteins have also implicated Rb family
members in the neuronal differentiation of PC12 cells by NGF
(4). A central mechanism by which Rb members presumably regulate the arrest and differentiation of neurons is via interactions with E2Fs. Consistent with this, the presence of free E2F complexes (i.e., lacking Rb family members) as well as the increased expression of an E2F target, the cyclin E gene, is associated with the altered proliferation of central nervous system neurons in Rb-deficient mice
(34).
The present studies suggest that E2F4 is an important transcriptional
regulator of the terminal differentiation of neuroblasts.
Expression of
E2F4 protein markedly increases in the rat cerebral
cortex and
cerebellum as neurons become postmitotic and is consistent
with the
pattern of E2F4 mRNA expression observed during neurogenesis
in the
mouse (
10). It has been found that E2F1, E2F2, and E2F5
mRNAs are downregulated while E2F4 transcripts are readily detected
in
postmitotic neurons of the mouse (
10,
50). E2F4 is also
upregulated following the differentiation of human neuroblastoma
cells
(
44). The demonstration of E2F4-p130 complexes following
the
neuronal differentiation of PC12 cells, together with the
required role
for p130 in neuronal development (
28), further
implicates
E2F4 in this
process.
Mechanisms of E2F4 action during differentiation.
The specific
mechanisms by which E2F4 enhances differentiation of PC12 cell-derived
neurons and possibly other cell types remain to be determined. E2F
complexes containing p130 predominate in the G0 state of
many differentiated cells and tissues (although complexes with other Rb
family members are also sometimes observed), and E2F4 is often the
major E2F species detected (8, 38, 42, 57). E2F-p130
complexes are thought to function by repressing the expression of genes
that are required for G1/S-phase transition and DNA
synthesis (24, 30). Thus, one mechanism by which E2F4 may
promote neuronal differentiation is by the repression of
G1/S-associated genes, which, in turn, would facilitate
cell cycle exit (Fig. 8). The
downregulation of E2F target genes, i.e., the cyclin A, p107, and pRb
genes as well as the gene for E2F1 itself, in differentiated PC12 cells
and neurons, as described here and in other studies (10, 21,
41), is consistent with this mechanism. However, E2F4 induction
had no effect on the growth regulation of PC12 cells by NGF, indicating
that additional, cell cycle-independent mechanisms are operative. In
particular, these results suggest that E2F4 may directly interact with
the differentiation program itself, either as complexes with p130 or in
some other form (Fig. 8). Both pRb and p21/WAF1 can influence cell
differentiation independent of their effects on the cell cycle
(12, 47), and E2F4 may also have dual yet distinct roles in
regulating cell growth and differentiation. The present study defines a
system in which these and other important aspects of E2F4 function
during cell differentiation can now be addressed.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 8.
Mechanisms by which E2F4 may facilitate the
differentiation process. E2F4 may act indirectly by downregulating the
expression of genes involved in cell cycle progression, thus promoting
growth arrest and subsequent differentiation, or by direct
participation in the differentiation process itself. In PC12 cells, its
effects appear to be largely independent of the cell cycle.
|
|
 |
ACKNOWLEDGMENTS |
We thank René Bernards and Hermann Bujard for providing us
with the E2F4 and tTA expression vectors, respectively, and Nicholas La
Thangue for E2F5 antiserum. We also thank Cathy Warren for her
assistance in preparing the manuscript.
This publication was made possible by PHS grant DK36468 as well as an
Annual Research Fund Award from the Worcester Foundation for Biomedical
Research to D.L.K.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Cellular and Molecular Physiology, University of Massachusetts Medical School, 55 Lake Ave. North, Worcester, MA 01655. Phone: (508) 856-6274. Fax: (508) 856-5997. E-mail: daniel.kilpatrick{at}ummed.edu.
Present address: Division of Infectious Diseases, Tufts University
School of Veterinary Medicine, North Grafton, MA 01536.
 |
REFERENCES |
| 1.
|
Altman, J.
1972.
Postnatal development of the cerebellar cortex in the rat.
J. Comp. Neurol.
145:465-514[Medline].
|
| 2.
|
Beijersbergen, R. L.,
L. Carlée,
R. M. Kerkhoven, and R. Bernards.
1995.
Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes.
Genes Dev.
9:1340-1353[Abstract/Free Full Text].
|
| 3.
|
Beijersbergen, R. L.,
R. M. Kerkhoven,
L. Zhu,
L. Carlée,
P. M. Voorhoeve, and R. Bernards.
1994.
E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo.
Genes Dev.
8:2680-2690[Abstract/Free Full Text].
|
| 4.
|
Boulukos, K. E., and E. B. Ziff.
1993.
Adenovirus 5 E1A proteins disrupt the neuronal phenotype and growth factor responsiveness of PC12 cells by a conserved region 1-dependent mechanism.
Oncogene
8:237-248[Medline].
|
| 5.
|
Brook, A.,
J. E. Xie,
W. Du, and N. Dyson.
1996.
Requirements for dE2F function in proliferating cells and in post-mitotic differentiating cells.
EMBO J.
15:3676-3683[Medline].
|
| 6.
|
Cartwright, P.,
H. Muller,
C. Wagener,
K. Holm, and K. Helin.
1998.
E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription.
Oncogene
17:611-623[Medline].
|
| 7.
|
Chong, J. A.,
J. Tapia-Ramirez,
S. Kim,
J. J. Toledo-Aral,
Y. Zheng,
M. C. Boutros,
Y. M. Altshuller,
M. A. Frohman,
S. D. Kraner, and G. Mandel.
1995.
REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons.
Cell
80:949-957[Medline].
|
| 8.
|
Corbeil, H. B., and P. E. Branton.
1997.
Characterization of an E2F-p130 complex formed during growth arrest.
Oncogene
15:657-668[Medline].
|
| 9.
|
Cowley, S.,
H. Paterson,
P. Kemp, and C. J. Marshall.
1994.
Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells.
Cell
77:841-852[Medline].
|
| 10.
|
Dagnino, L.,
C. J. Fry,
S. M. Bartley,
P. Farnham,
B. L. Gallie, and R. A. Phillips.
1997.
Expression patterns of the E2F family of transcription factors during mouse nervous system development.
Mech. Dev.
66:13-25[Medline].
|
| 11.
|
Dagnino, L.,
C. J. Fry,
S. M. Bartley,
P. Farnham,
B. L. Gallie, and R. A. Phillips.
1997.
Expression patterns of the E2F family of transcription factors during murine epithelial development.
Cell Growth Differ.
8:553-563[Abstract].
|
| 12.
|
Di Cunto, F.,
G. Topley,
E. Calautti,
J. Hsiao,
L. Ong,
P. K. Seth, and G. P. Dotto.
1998.
Inhibitory function of p21Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control.
Science
280:1069-1072[Abstract/Free Full Text].
|
| 13.
|
Gaubatz, S.,
J. G. Wood, and D. M. Livingston.
1998.
Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6.
Proc. Natl. Acad. Sci. USA
95:9190-9195[Abstract/Free Full Text].
|
| 14.
|
Gonzalez-Sanchez, A., and D. Bader.
1990.
In vitro analysis of cardiac progenitor cell differentiation.
Dev. Biol.
139:197-209[Medline].
|
| 15.
|
Greene, L. A.
1978.
Nerve growth factor prevents the death and stimulates the neuronal differentiation of clonal PC12 pheochromocytoma cells in serum-free medium.
J. Cell Biol.
78:747-755[Abstract/Free Full Text].
|
| 16.
|
Greene, L. A., and A. S. Tischler.
1976.
Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.
Proc. Natl. Acad. Sci. USA
73:2424-2428[Abstract/Free Full Text].
|
| 17.
|
Gu, W.,
J. W. Schneider,
G. Condorelli,
S. Kaushal,
V. Mahdavi, and B. Nadal-Ginard.
1993.
Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation.
Cell
72:309-324[Medline].
|
| 18.
|
Halegoua, S.,
R. C. Armstrong, and N. E. Kremer.
1991.
Dissecting the mode of action of a neuronal growth factor.
Curr. Top. Microbiol. Immunol.
165:119-170[Medline].
|
| 19.
|
Halevy, O.,
B. G. Novitch,
D. B. Spicer,
S. X. Skapek,
J. Rhee,
G. J. Hannon,
D. Beach, and A. B. Lassar.
1995.
Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by myoD.
Science
267:1018-1021[Abstract/Free Full Text].
|
| 20.
|
Hass, R.,
H. Gunji,
R. Datta,
S. Kharbanda,
A. Hartmann,
R. Weichselbaum, and D. Kufe.
1992.
Differentiation and retrodifferentiation of human myeloid leukemia cells is associated with reversible induction of cell cycle-regulatory genes.
Cancer Res.
52:1445-1450[Abstract/Free Full Text].
|
| 21.
|
Hayes, T. E.,
N. L. M. Valtz, and R. D. G. McKay.
1991.
Downregulation of CDC2 upon terminal differentiation of neurons.
New Biol.
3:259-269[Medline].
|
| 22.
|
Helin, K.
1998.
Regulation of cell proliferation by the E2F transcription factors.
Curr. Opin. Genet. Dev.
8:28-35[Medline].
|
| 23.
|
Hijmans, E. M.,
P. M. Voorhoeve,
R. L. Beijersbergen,
L. J. van 't Veer, and R. Bernards.
1995.
E2F-5, a new E2F family member that interacts with p130 in vivo.
Mol. Cell. Biol.
15:3082-3089[Abstract/Free Full Text].
|
| 24.
|
Hurford, R. K., Jr.,
D. Cobrinik,
M.-H. Lee, and N. Dyson.
1997.
pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes.
Genes Dev.
11:1447-1463[Abstract/Free Full Text].
|
| 25.
|
Kadonaga, J. T.,
K. R. Carner,
F. R. Masiarz, and R. Tjian.
1987.
Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain.
Cell
51:1079-1090[Medline].
|
| 26.
|
Kaelin, W. G., Jr.,
W. Krek,
W. R. Sellers,
J. A. DeCaprio,
F. Ajchenbaum,
C. S. Fuchs,
T. Chittenden,
L. Yue,
P. J. Farnham,
M. A. Blanar,
D. M. Livingston, and E. K. Flemington.
1992.
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties.
Cell
70:351-364[Medline].
|
| 27.
|
Kew, D., and D. L. Kilpatrick.
1990.
Widespread organ expression of the rat proenkephalin gene during early postnatal development.
Mol. Endocrinol.
4:337-340[Abstract/Free Full Text].
|
| 28.
|
LeCouter, J. E.,
B. Kablar,
P. F. Whyte,
C. Ying, and M. A. Rudnicki.
1998.
Strain-dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene.
Development
125:4669-4679[Abstract].
|
| 29.
|
Lee, E. Y.-H. P.,
N. Hu,
S.-S. F. Yuan,
L. A. Cox,
A. Bradley,
W.-H. Lee, and K. Herrup.
1994.
Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation.
Genes Dev.
8:2008-2021[Abstract/Free Full Text].
|
| 30.
|
Li, J.-M.,
P. P.-C. Hu,
X. Shen,
Y. Yu, and X.-F. Wang.
1997.
E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor through E2F binding sites.
Proc. Natl. Acad. Sci. USA
94:4948-4953[Abstract/Free Full Text].
|
| 31.
|
Lindeman, G. J.,
L. Dagnino,
S. Gaubatz,
Y. Xu,
R. T. Bronson,
H. B. Warren, and D. M. Livingston.
1998.
A specific, nonproliferative role for E2F-5 in choroid plexus function revealed by gene targeting.
Genes Dev.
12:1092-1098[Abstract/Free Full Text].
|
| 32.
|
Lindeman, G. J.,
S. Gaubatz,
D. M. Livingston, and D. Ginsberg.
1997.
The subcellular localization of E2F-4 is cell-cycle dependent.
Proc. Natl. Acad. Sci. USA
94:5095-5100[Abstract/Free Full Text].
|
| 33.
|
Lukas, J.,
B. O. Petersen,
K. Holm,
J. Bartek, and K. Helin.
1996.
Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression.
Mol. Cell. Biol.
16:1047-1057[Abstract/Free Full Text].
|
| 34.
|
Macleod, K. F.,
Y. Hu, and T. Jacks.
1996.
Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system.
EMBO J.
15:6178-6188[Medline].
|
| 35.
|
Magae, J.,
C.-L. Wu,
S. Illenye,
E. Harlow, and N. H. Heintz.
1996.
Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members.
J. Cell Sci.
109:1717-1726[Abstract].
|
| 36.
|
McConnell, S. K.
1995.
Constructing the cerebral cortex: neurogenesis and fate determination.
Neuron
15:761-768[Medline].
|
| 37.
|
Mesner, P. W.,
T. R. Winters, and S. H. Green.
1992.
Nerve growth factor withdrawal-induced cell death in neuronal PC12 cells resembles that in sympathetic neurons.
J. Cell Biol.
119:1669-1680[Abstract/Free Full Text].
|
| 38.
|
Moberg, K.,
M. A. Starz, and J. A. Lees.
1996.
E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry.
Mol. Cell. Biol.
16:1436-1449[Abstract/Free Full Text].
|
| 39.
|
Müller, R.
1995.
Transcriptional regulation during the mammalian cell cycle.
Trends Genet.
11:173-178[Medline].
|
| 40.
|
Nevins, J. R.
1998.
Toward an understanding of the functional complexity of the E2F and retinoblastoma families.
Cell Growth Differ.
9:585-593[Medline].
|
| 41.
|
Okano, H. J.,
D. W. Pfaff, and R. B. Gibbis.
1993.
RB and Cdc2 expression in brain: correlations with 3H-thymidine incorporation and neurogenesis.
J. Neurosci.
13:2930-2938[Abstract].
|
| 42.
|
Puri, P. L.,
C. Balsano,
V. L. Burgio,
P. Chirillo,
G. Natoli,
L. Ricci,
E. Mattei,
A. Graessmann, and M. Levrero.
1997.
MyoD prevents cyclinA/cdk2 containing E2F complexes formation in terminally differentiated myocytes.
Oncogene
14:1171-1184[Medline].
|
| 43.
|
Puri, P. L.,
L. Cimino,
M. Fulco,
C. Zimmerman,
N. B. La Thangue,
A. Giordano,
A. Graessmann, and M. Levrero.
1998.
Regulation of E2F4 mitogenic activity during terminal differentiation by its heterodimerization partners for nuclear translocation.
Cancer Res.
58:1325-1331[Abstract/Free Full Text].
|
| 44.
|
Raschella, G.,
B. Tanno,
F. Bonetto,
R. Amendola,
T. Battista,
A. De Luca,
A. Giordano, and M. G. Paggi.
1997.
Retinoblastoma-related protein pRb2/p130 and its binding to the B-myb promoter increase during human neuroblastoma differentiation.
J. Cell. Biochem.
67:297-303[Medline].
|
| 45.
|
Ross, M. E.
1996.
Cell division and the nervous system: regulating the cycle from neural differentiation to death.
Trends Neurosci.
19:62-68[Medline].
|
| 46.
|
Sardet, C.,
M. Vidal,
D. Cobrinik,
Y. Geng,
C. Onufryk,
A. Chen, and R. A. Weinberg.
1995.
E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle.
Proc. Natl. Acad. Sci. USA
92:2403-2407[Abstract/Free Full Text].
|
| 47.
|
Sellers, W. R.,
B. G. Novitch,
S. Miyake,
A. Heith,
G. A. Otterson,
F. J. Kaye,
A. B. Lassar, and W. G. Kaelin, Jr.
1998.
Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth.
Genes Dev.
12:95-106[Abstract/Free Full Text].
|
| 48.
|
Smith, E. J.,
G. Leone,
J. DeGregori,
L. Jakoi, and J. R. Nevins.
1996.
The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state.
Mol. Cell. Biol.
16:6965-6976[Abstract/Free Full Text].
|
| 49.
|
Strom, A.,
P. Castella,
J. Rockwood,
J. Wagner, and M. Caudy.
1997.
Mediation of NGF signaling by post-translational inhibition of HES-1, a basic helix-loop-helix repressor of neuronal differentiation.
Genes Dev.
11:3168-3181[Abstract/Free Full Text].
|
| 50.
|
Tevosian, S. G.,
K. E. Paulson,
R. Bronson, and A. S. Yee.
1996.
Expression of the E2F-1/DP-1 transcription factor in murine development.
Cell Growth Differ.
7:43-52[Abstract].
|
| 51.
|
Trimarchi, J. M.,
B. Fairchild,
R. Verona,
K. Moberg,
N. Andon, and J. A. Lees.
1998.
E2F-6, a member of the E2F family that can behave as a transcriptional repressor.
Proc. Natl. Acad. Sci. USA
95:2850-2855[Abstract/Free Full Text].
|
| 52.
|
Tso, J. Y.,
X. H. Sun,
T. H. Kao,
K. S. Reece, and R. Wu.
1985.
Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene.
Nucleic Acids Res.
13:2485-2502[Abstract/Free Full Text].
|
| 53.
|
Vairo, G.,
D. M. Livingston, and D. Ginsberg.
1995.
Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members.
Genes Dev.
9:869-881[Abstract/Free Full Text].
|
| 54.
|
Verona, R.,
K. Moberg,
S. Estes,
M. Starz,
J. P. Vernon, and J. A. Lees.
1997.
E2F activity is regulated by cell cycle-dependent changes in subcellular localization.
Mol. Cell. Biol.
17:7268-7282[Abstract/Free Full Text].
|
| 55.
|
Wang, J.,
X. Chenivesse,
B. Henglein, and C. Bréchot.
1990.
Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma.
Nature
343:555-557[Medline].
|
| 56.
|
Williams, C. D.,
D. C. Linch,
T. S. Sorensen,
N. B. La Thangue, and N. S. B. Thomas.
1997.
The predominant E2F complex in human primary haemopoietic cells and in AML blasts contains E2F-4, DP-1 and p130.
Br. J. Haematol.
96:686-696.
|
| 57.
|
Williams, C. D.,
D. C. Linch,
M. J. Watts, and N. S. Thomas.
1997.
Characterization of cell cycle status and E2F complexes in mobilized CD34+ cells before and after cytokine stimulation.
Blood
90:194-203[Abstract/Free Full Text].
|
| 58.
|
Yan, G. Z., and E. B. Ziff.
1997.
Nerve growth factor induces transcription of the p21 WAF1/CIP1 and cyclin D1 genes in PC12 cells by activating the Sp1 transcription factor.
J. Neurosci.
17:6122-6132[Abstract/Free Full Text].
|
| 59.
|
Yan, G.-Z., and E. B. Ziff.
1995.
NGF regulates the PC12 cell cycle machinery through specific inhibition of the Cdk kinases and induction of cyclin D1.
J. Neurosci.
15:6200-6212[Abstract].
|
Molecular and Cellular Biology, September 1999, p. 6048-6056, Vol. 19, No. 9
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Zhou, F., Zhang, L., Wang, A., Song, B., Gong, K., Zhang, L., Hu, M., Zhang, X., Zhao, N., Gong, Y.
(2008). The Association of GSK3{beta} with E2F1 Facilitates Nerve Growth Factor-induced Neural Cell Differentiation. J. Biol. Chem.
283: 14506-14515
[Abstract]
[Full Text]
-
Enos, M. E., Bancos, S. A., Bushnell, T., Crispe, I. N.
(2008). E2F4 Modulates Differentiation and Gene Expression in Hematopoietic Progenitor Cells during Commitment to the Lymphoid Lineage. J. Immunol.
180: 3699-3707
[Abstract]
[Full Text]
-
Ahuja, P., Sdek, P., MacLellan, W. R.
(2007). Cardiac Myocyte Cell Cycle Control in Development, Disease, and Regeneration. Physiol. Rev.
87: 521-544
[Abstract]
[Full Text]
-
Rodriguez, J. M., Glozak, M. A., Ma, Y., Cress, W. D.
(2006). Bok, Bcl-2-related Ovarian Killer, Is Cell Cycle-regulated and Sensitizes to Stress-induced Apoptosis. J. Biol. Chem.
281: 22729-22735
[Abstract]
[Full Text]
-
Liu, D. X., Nath, N., Chellappan, S. P., Greene, L. A.
(2005). Regulation of neuron survival and death by p130 and associated chromatin modifiers. Genes Dev.
19: 719-732
[Abstract]
[Full Text]
-
Karsan, A., Pollet, I., Yu, L.-R., Chan, K. C., Conrads, T. P., Lucas, D. A., Andersen, R., Veenstra, T.
(2005). Quantitative Proteomic Analysis of Sokotrasterol Sulfate-stimulated Primary Human Endothelial Cells. Mol. Cell. Proteomics
4: 191-204
[Abstract]
[Full Text]
-
Kobayashi, M., Taniura, H., Yoshikawa, K.
(2002). Ectopic Expression of Necdin Induces Differentiation of Mouse Neuroblastoma Cells. J. Biol. Chem.
277: 42128-42135
[Abstract]
[Full Text]
-
He, Y., Cress, W. D.
(2002). E2F-3B Is a Physiological Target of Cyclin A. J. Biol. Chem.
277: 23493-23499
[Abstract]
[Full Text]
-
Myster, D., Bonnette, P., Duronio, R.
(2000). A role for the DP subunit of the E2F transcription factor in axis determination during Drosophila oogenesis. Development
127: 3249-3261
[Abstract]
-
Carroll, J. S., Prall, O. W. J., Musgrove, E. A., Sutherland, R. L.
(2000). A Pure Estrogen Antagonist Inhibits Cyclin E-Cdk2 Activity in MCF-7 Breast Cancer Cells and Induces Accumulation of p130-E2F4 Complexes Characteristic of Quiescence. J. Biol. Chem.
275: 38221-38229
[Abstract]
[Full Text]
-
Paramio, J. M., Segrelles, C., Casanova, M. L., Jorcano, J. L.
(2000). Opposite Functions for E2F1 and E2F4 in Human Epidermal Keratinocyte Differentiation. J. Biol. Chem.
275: 41219-41226
[Abstract]
[Full Text]